Immix Biopharma, Inc

11400 W Olympic Blvd Ste 200
Los Angeles, CA 90064

Immix Biopharma, Inc., based in Los Angeles, CA, is a pioneering company focused on the development of innovative cell therapies for AL amyloidosis and other serious diseases. Their lead product, NXC-201, utilizes advanced sterically-optimized CAR-T technology, aiming to redefine treatment protocols and enhance patient outcomes within the realm of oncology.

With a commitment to addressing critical challenges in the treatment of serious diseases, Immix Biopharma is actively conducting clinical trials and expanding its therapeutic platform. The company is positioned as a key player in the healthcare sector, offering significant potential for both patient impact and investor interest.

Generated from the website

Own this business?
See a problem?

You might also like

United StatesCaliforniaLos AngelesImmix Biopharma, Inc

Partial Data by Infogroup (c) 2025. All rights reserved.